Advertisement
Canada markets close in 6 hours 6 minutes

  • S&P/TSX

    22,118.37
    +170.96 (+0.78%)
     

  • S&P 500

    5,157.58
    +29.79 (+0.58%)
     

  • DOW

    38,823.45
    +147.77 (+0.38%)
     

  • CAD/USD

    0.7324
    +0.0015 (+0.21%)
     

  • CRUDE OIL

    78.61
    +0.50 (+0.64%)
     

  • Bitcoin CAD

    87,298.04
    -323.41 (-0.37%)
     

  • CMC Crypto 200

    1,368.88
    +56.25 (+4.28%)
     

  • GOLD FUTURES

    2,335.30
    +26.70 (+1.16%)
     

  • RUSSELL 2000

    2,053.93
    +18.21 (+0.89%)
     

  • 10-Yr Bond

    4.5020
    +0.0020 (+0.04%)
     

  • NASDAQ

    16,254.15
    +97.82 (+0.61%)
     

  • VOLATILITY

    13.70
    +0.21 (+1.56%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • CAD/EUR

    0.6788
    +0.0001 (+0.01%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AT OPEN AS RALLY LOOKS SET TO CONTINUE

Equities rallied at end of last week, getting a boost from a "Goldilocks" U.S. jobs print

CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors

Reuters
·1 min read

April 4 (Reuters) - CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp, will add Perrigo's birth control pill to its preventive services oral contraceptives list and make it available at no cost for many plan sponsors, according to a pharmacy update on March 28.

The U.S. FDA in July approved over-the-counter use of Perrigo's drug Opill, making it the first oral contraceptive in the country which can be purchased without prescription.

Opill was first approved for prescription use in 1973.

Last month, Perrigo said Opill would be available at major retailers for a price of $19.99 and $49.99 for a one-month and three-month supply, respectively.

On Thursday, drugstore chain operator Rite Aid said Opill would be available at its pharmacies in all locations. (Reporting by Christy Santhosh and Aishwarya Jain in Bengaluru; Editing by Vijay Kishore)